Text Size

Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits

Arnold J.J., Choksi Y., Chen X., Shimazaki A., Hatten J., Toone E.J., Epstein D.L., Challa P.


  • 2009
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    Department of Ophthalmology, Duke University School of Medicine, Duke University, Durham, NC, United States; Department of Chemistry, Duke University School of Medicine, Duke University, Durham, NC, United States; Santen Pharmaceutical Co Ltd., Tokyo, Japan; Department of Pharmaceutical, Social, and Administrative Sciences, Samford University McWhorter School of Pharmacy, Birmingham, AL, United States; Duke Eye Center, Box 3802 DUMC, Durham, NC 27710, United States

Related Publications

An Exploratory Study of Machine Learning-Based Open-Angle Glaucoma Detection Using Specific Autoantibodies

Takada N., Ishikawa M., Ninomiya T., Izumi Y., Sato K., Kunikata H., Yokoyama Y., Tsuda S., Fukuda E., Yamaguchi K., Ono C., Kirihara T., Shintani C., Hanyuda A., Goshima N., Zorumski C.F., NakazawaT.


Relaxation of Precontracted Ciliary Artery and Ciliary Muscle In Vitro by Kinin Peptides: Relevance to Retinal Blood Flow and Intraocular Pressure Regulation

Sharif N.A., Kulkarni-Chitnis M., Okolie A., Chaudhry S.D., Njie-Mbye Y.F., Ohia S.E.


The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost, a Novel Dual Agonist of FP and EP3 Receptors, in Monkeys

Maki K., Kimura E., Yamamoto Y., Fuwa M., Toris C.B., Fan S., Shimazaki A., Kato M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022